Illumina DRAGEN GCP Lvl 4 1-year License
This federal contract opportunity closed on September 10, 2026. The deadline for submissions has passed.
This opportunity has closed
Response deadline was September 10, 2026
Similar active opportunities you might be interested in:
- TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via CondensationDue: December 23, 2026
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)Due: October 18, 2027
- Non-Optical Methods for High Speed Protein ControlDue: January 1, 2027
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in BETHESDA, MD
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
- Advance notice of upcoming solicitation
Contract Details
- Notice ID
- 75N98026Q01035
- Opportunity Type
- Presolicitation
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Posted Date
- Wednesday, September 2, 2026
- Response Deadline
- Thursday, September 10, 2026
- PSC Code
- 7A21
- Set-Aside
- No Set Aside
- Place of Performance
- BETHESDA, MD, 20892
- Status
- Active
Description
The National Institute of Neurological Disorders and Stroke (NINDS), Neurodegenerative Diseases Research Section (NDRS), requires a 12-month subscription/access to the Illumina DRAGEN GCP Level 4 platform to process approximately 1,300,000 GB of whole-genome sequencing data derived from 10,000 human genomes. The platform must support graph-based alignment to the human reference genome (hg38), accurate variant calling, and detection of single-nucleotide variants, insertions/deletions, structural variants, copy number variants, and repeat expansions. The platform must be fully compatible with Illumina-generated sequencing data and existing DRAGEN-processed datasets. The contractor shall provide access and operational availability of the DRAGEN GCP platform and processing capability sufficien
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
